Company news
Atea Pharmaceuticals, Inc. news in 2023
Atea Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.
Atea Pharmaceuticals Presents Promising Bemnifosbuvir and Ruzasvir Combination Data for the Treatment of Hepatitis C Virus at AASLD The Liver Meeting 2023
November 12, 2023
Atea Pharmaceuticals Announces Participation at Upcoming Investor Conferences
November 7, 2023
Atea Pharmaceuticals to Host Third Quarter 2023 Financial Results Conference Call on November 8, 2023
October 31, 2023
Atea Pharmaceuticals to Host Second Quarter 2023 Financial Results Conference Call on August 8, 2023
July 31, 2023
Atea Pharmaceuticals Announces First Patient Dosed in Phase 2 Study for Treatment of Hepatitis C with Bemnifosbuvir and Ruzasvir Combination
June 14, 2023
Atea Pharmaceuticals’ Board of Directors Unanimously Rejects Unsolicited Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences
May 29, 2023
Atea Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update
May 7, 2023
Atea Pharmaceuticals to Host First Quarter 2023 Financial Results Conference Call on May 8, 2023
April 30, 2023
Atea Pharmaceuticals Announces U.S. FDA Fast Track Designation Granted to Bemnifosbuvir, an Investigational Oral Antiviral, for the Treatment of COVID-19
April 24, 2023
Atea Announces Presentation of Bemnifosbuvir Data Demonstrating Reduced Hospitalizations for COVID-19 Patients at 2023 European Congress of Clinical Microbiology & Infectious Diseases
April 11, 2023
Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
February 27, 2023
Atea Pharmaceuticals Presents Favorable Drug Interaction Profile of Bemnifosbuvir in Phase 1 Studies at CROI 2023
February 22, 2023
Atea Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on February 28, 2023
February 20, 2023
Atea Pharmaceuticals Highlights Strategic Priorities for 2023
January 8, 2023
Calls in 2023
- Atea Pharmaceuticals (NASDAQ:AVIR) Q3 2023 Earnings Call
Nov 8, 2023
Transcript - Atea Pharmaceuticals (NASDAQ:AVIR) Q2 2023 Earnings Call
Aug 8, 2023
Transcript - Atea Pharmaceuticals (NASDAQ:AVIR) Q1 2023 Earnings Call
May 8, 2023
Transcript - Atea Pharmaceuticals (NASDAQ:AVIR) Q4 2022 Earnings Call
Feb 28, 2023
Transcript